CASP3 and acute myeloid leukemia: ,6,7,8 However, active killing of AML primary isolates by ara-C can be caspase independent,10 and caspase-3 activation trends failed to predict ara-C and anthracycline drug sensitivity of primary AML isolates from 42 patients.17